Pharma Journalist -

Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox. Hyundai Bioscience has decided to submit a request for a fast track…
Read More...

Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced that the U.S. Food and Drug Administration (FDA) approved TIBSOVO …
Read More...

Genomic Testing Cooperative (GTC) announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its liquid biopsy profiles for both solid tumors and…
Read More...

Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company using two lentiviral platforms to develop and commercialize therapies for genetic diseases, announced an…
Read More...

Cornerstone Pharmaceuticals, Inc. a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, announced that the European Medicines Agency (EMA) has…
Read More...

Halozyme Therapeutics, Inc. announced the successful completion of its acquisition of Antares Pharma, Inc. ("Antares"). The tender offer for all of the outstanding shares of Antares…
Read More...

A faculty member in the College of Pharmacy and Health Sciences at St. John’s University recently received a $492,000 federal grant to develop a COVID-19 vaccine that will be…
Read More...

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of a novel preclinical candidate (PCC)…
Read More...

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company's Abbreviated New Drug Application ("ANDA") for Regadenoson injection, 0.08…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy as…
Read More...